• News

“La Caixa” Foundation makes visible Dra. Figueroa project. She briefly explains what’s next on her CaixaImpulse Validate project

“At present, our immediate goal is to select compounds exhibiting drug-like properties and potential for further optimization towards a candidate drug that could enter the regulatory preclinical development phase.” Angélica and her group have identified novel small-molecule inhibitors intended as therapy for metastatic colon cancer.